NCT04931186View on ClinicalTrials.gov

Nasolacrimal Duct Obstruction

CompletedOBSERVATIONAL
Enrollment

625

Participants

Timeline

Start Date

July 3, 2018

Primary Completion Date

February 6, 2020

Study Completion Date

June 11, 2020

Conditions
Eye DiseasesLacrimal Duct Obstruction
Interventions
OTHER

retrospective analyis

retrospective analysis of data

Trial Locations (1)

1090

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT04931186 - Nasolacrimal Duct Obstruction | Biotech Hunter | Biotech Hunter